COMMUNIQUÉS West-GlobeNewswire

-
Arbutus to Participate in Two Upcoming Investor Conferences
07/05/2024 -
Altimmune to Participate at Two Upcoming Investor Conferences
07/05/2024 -
Enable Injections Expands Strategic Partnership with Roche
07/05/2024 -
ITM Appoints Dr. Danielle Meyrick as Chief Medical Officer
07/05/2024 -
Coloplast Finance B.V. - Interim Financial Report, H1 2023/24
07/05/2024 -
EyeDNA Therapeutics Announces Positive 24-month Data Presented at ARVO from Ongoing Phase I/II Trial of HORA-PDE6b Gene Therapy in Patients with Retinitis Pigmentosa Caused by Bi-allelic Mutations in PDE6b
07/05/2024 -
CMR Surgical appoints Shlomi Cohen as Chief Financial Officer
07/05/2024 -
Memo Therapeutics increases Series C financing to CHF 45 million
07/05/2024 -
Orion Corporation: Change in Orion Group Executive Management Board as of 31 May 2025
07/05/2024 -
Coloplast strengthens ostomy care portfolio with three significant product launches
07/05/2024 -
Coloplast A/S - Announcement no. 02/2024 - Interim Financial Report, H1 2023/24
07/05/2024 -
Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates
07/05/2024 -
Valneva publie ses résultats financiers du premier trimestre 2024 et fait un point sur ses activités
07/05/2024 -
argenx to Present at BofA Securities 2024 Health Care Conference
07/05/2024 -
Ultimovacs ASA Reports First Quarter 2024 Financial Results and Provides General Business Update
07/05/2024 -
Sandoz reports first quarter 2024 sales
07/05/2024 -
BioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF 12.3 Million
07/05/2024 -
Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering
07/05/2024 -
Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/05/2024
Pages